{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:35:30Z","timestamp":1740123330131,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Key Innovative Team of Shanghai Top-Level University Capacity Building in Clinical Pharmacy and Regulatory Science at Shanghai Medical School of Fudan University","award":["HJW-R-2019-66-19"],"award-info":[{"award-number":["HJW-R-2019-66-19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10792-021-02076-6","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T21:28:40Z","timestamp":1634074120000},"page":"945-950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The use of fixed dose drug combinations for glaucoma in clinical settings: a retrospective, observational, single-centre study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5689-9989","authenticated-orcid":false,"given":"Jingchao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taomin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"2076_CR1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901\u20131911","journal-title":"JAMA"},{"key":"2076_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA (2011) Glaucoma. Lancet 377:1367\u20131377","journal-title":"Lancet"},{"key":"2076_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262\u2013267","journal-title":"Br J Ophthalmol"},{"key":"2076_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/bjophthalmol-2018-313308","volume":"104","author":"CY Cheng","year":"2020","unstructured":"Cheng CY, Wang N, Wong TY et al (2020) Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections. Br J Ophthalmol 104:616\u2013622","journal-title":"Br J Ophthalmol"},{"key":"2076_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/14656566.2020.1743264","volume":"21","author":"L Machen","year":"2020","unstructured":"Machen L, Razeghinejad R, Myers JS (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opin Pharmacother 21:1269\u20131282","journal-title":"Expert Opin Pharmacother"},{"key":"2076_CR6","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s10792-017-0601-8","volume":"38","author":"S Guven Yilmaz","year":"2018","unstructured":"Guven Yilmaz S, Degirmenci C, Karakoyun YE, Yusifov E, Ates H (2018) The efficacy and safety of bimatoprost\/timolol maleate, latanoprost\/timolol maleate, and travoprost\/timolol maleate fixed combinations on 24-h IOP. Int Ophthalmol 38:1425\u20131431","journal-title":"Int Ophthalmol"},{"key":"2076_CR7","first-page":"164","volume":"65","author":"M Alaei","year":"2015","unstructured":"Alaei M, Najmi AK, Kausar H, Akhtar M (2015) A prospective research study of anti-glaucoma drugs prescribing, utilization pattern and adverse drug reaction recording in a university hospital. Drug Res (Stuttg) 65:164\u2013168","journal-title":"Drug Res (Stuttg)"},{"key":"2076_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2298\/SARH1510626B","volume":"143","author":"N Babi\u0107","year":"2015","unstructured":"Babi\u0107 N (2015) Fixed combinations of glaucoma medications. Srp Arh Celok Lek 143:626\u2013631","journal-title":"Srp Arh Celok Lek"},{"key":"2076_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40123-018-0150-x","volume":"7","author":"R Moosavi","year":"2018","unstructured":"Moosavi R, Ansari E (2018) Brinzolamide\/brimonidine fixed combination: simplifying glaucoma treatment regimens. Ophthalmol Ther 7:397\u2013403","journal-title":"Ophthalmol Ther"},{"key":"2076_CR10","doi-asserted-by":"publisher","first-page":"e0227595","DOI":"10.1371\/journal.pone.0227595","volume":"15","author":"L Yu","year":"2020","unstructured":"Yu L, Ding K, Luo L, Yu Z (2020) Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017. PLoS One 15:e0227595","journal-title":"PLoS One"},{"key":"2076_CR11","doi-asserted-by":"publisher","first-page":"P41","DOI":"10.1016\/j.ophtha.2015.10.053","volume":"123","author":"BE Prum Jr","year":"2016","unstructured":"Prum BE Jr, Rosenberg LF, Gedde SJ, Mansberger SL et al (2016) Primary open-angle glaucoma preferred practice pattern (\u00ae) guidelines. Ophthalmology 123:P41\u2013P111","journal-title":"Ophthalmology"},{"key":"2076_CR12","doi-asserted-by":"publisher","unstructured":"EGS-European Glaucoma Society (2017) European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and terminology Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol 101 73\u2013127. doi: https:\/\/doi.org\/10.1136\/bjophthalmol-2016-EGSguideline.002","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.002"},{"key":"2076_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2165\/00002512-200724120-00004","volume":"24","author":"AS Khouri","year":"2007","unstructured":"Khouri AS, Realini T, Fechtner RD (2007) Use of fixed-dose combination drugs for the treatment of glaucoma. Drugs Aging 24:1007\u20131016","journal-title":"Drugs Aging"},{"key":"2076_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10792-019-01194-6","volume":"40","author":"P K\u00f3thy","year":"2020","unstructured":"K\u00f3thy P, Holl\u00f3 G (2020) Real-life experience of using brinzolamide\/brimonidine fixed drop combination in a tertiary glaucoma centre. Int Ophthalmol 40:377\u2013383","journal-title":"Int Ophthalmol"},{"key":"2076_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14656566.2019.1685499","volume":"21","author":"S Sinha","year":"2020","unstructured":"Sinha S, Lee D, Kolomeyer NN, Myers JS, Razeghinejad R (2020) Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension. Expert Opin Pharmacother 21:39\u201345","journal-title":"Expert Opin Pharmacother"},{"key":"2076_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1080\/14740338.2020.1826928","volume":"19","author":"AG Konstas","year":"2020","unstructured":"Konstas AG, Schmetterer L, Costa VP et al (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opin Drug Saf 19:1445\u20131460","journal-title":"Expert Opin Drug Saf"},{"key":"2076_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2147\/PPA.S131853","volume":"28","author":"X Sun","year":"2017","unstructured":"Sun X, Lin M, Duan X, Zhang C, Ming J (2017) Patient satisfaction with fixed-combination bimatoprost\/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Prefer Adher 28:845\u2013852","journal-title":"Patient Prefer Adher"},{"key":"2076_CR18","first-page":"1","volume":"10","author":"C Xu","year":"2020","unstructured":"Xu C, Guo R, Huang D, Ji J, Liu W (2020) Daily costs and cost effectiveness of glaucoma fixed combinations in China. J Ophthalmol 10:1\u20135","journal-title":"J Ophthalmol"},{"key":"2076_CR19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaophthalmol.2015.1671","volume":"133","author":"DM Blumberg","year":"2015","unstructured":"Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG (2015) Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of medicare part D. JAMA Ophthalmol 133:985\u2013996","journal-title":"JAMA Ophthalmol"},{"key":"2076_CR20","unstructured":"Ministry Of Health, The People's Republic of China, Prescription Management Measures. 2007. Accessed July 2021. Available from: http:\/\/www.nhc.gov.cn\/fzs\/s3576\/201808\/d71d4735f6c842158d2757fbaa553b80.shtml"},{"key":"2076_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/ceo.13156","volume":"46","author":"BK Lakhani","year":"2018","unstructured":"Lakhani BK, King AJ (2018) Exploring the frequency and location of prescribing errors in the use of topical glaucoma medications. Clin Exp Ophthalmol 46:616\u2013623","journal-title":"Clin Exp Ophthalmol"},{"key":"2076_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-020-01508-8","volume":"20","author":"K Kashiwagi","year":"2020","unstructured":"Kashiwagi K, Chono E, Koesters S, Yap PS (2020) Persistence and treatment patterns of fixed combination drugs for glaucoma: a retrospective claims database study in Japan. BMC Ophthalmol 20:1\u201311","journal-title":"BMC Ophthalmol"},{"key":"2076_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/OPTH.S231402","volume":"23","author":"N Wang","year":"2020","unstructured":"Wang N, Lu DW, Pan Y et al (2020) Comparison of the intraocular pressure-lowering efficacy and safety of the brinzolamide\/brimonidine fixed-dose combination versus concomitant use of brinzolamide and brimonidine for management of open-angle glaucoma or ocular hypertension. Clin Ophthalmol 23:221\u2013230","journal-title":"Clin Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-02076-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T16:48:46Z","timestamp":1647017326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-02076-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2076"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-02076-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}